ESTRO Guide 2019

Multidisciplinary Management of Non-melanoma Skin Cancer 7-9 November 2019 | Brussels, Belgium

TARGET GROUP This advanced multidisciplinary course is aimed at radiation oncologists and clinical oncologists, dermatologists, Mohs’ surgeons, plastic surgeons, allied health care professionals and other specialists and trainees who have a special interest in non-melanoma skin cancer (NMSC) and would like to update their knowledge in the multidisciplinary management of patients with NMSC. The course may also be of interest to medical physicists and radiographers who would like an overview of the current practice in NMSC. practices, and highlights the challenges in palliative and supportive care for patients. As the incidence of non- melanoma skin cancer increases worldwide, this interactive course highlights the need to improve interdisciplinary collaboration. It includes the advantages and disadvantages of imaging modalities for diagnosis and treatment, improves understanding of best

particularly in NMSC. NMSC is the most common malignancy but its public significance is often unrecognised. Although mortality fromNMSC is rare in the general population, treatment of NMSC is becoming a considerable burden for health care services across the world due to rapidly increasing number of new cases, aging population and increased complexity of cases, often requiring a specialist multidisciplinary approach. The course will be interactive and including a varietyofteachingmethods.Therewillbealso special sessions covering extended content dedicated to Mohs’ and plastic surgery, and skin radiotherapy, brachytherapy and radiobiology for those participants who wish for advanced knowledge in the relevant fields. COURSE AIM This course aims to bring various specialists and trainees in the field of dermato- oncology in order to bridge gaps between specialisations, increase multidisciplinary understanding and highlight the need for improved interdisciplinary collaboration. The course will be interactive through integration of multidisciplinary lectures and more focused workshops, debates and case discussions. The faculty includes renowned

experts involved in the multidisciplinary treatment of NMSC. It is hoped that the course will serve a vital reference for all professionals involved in the management of NMSC. LEARNINGOUTCOMES By the end of this course participants should be able to: • Understand prophylaxis, epidemiology and pathology of NMSC with special focus on basal, squamous and Merkel cell carcinoma. Rare skin cancers will also be included. • Discuss advantages and limitations of imaging modalities used for diagnosis and treatment of NMSC • Understand indications and limitations of surgical and non-surgical treatment modalities in NMSC • Develop a deep understanding of best practices in NMSC and provide patients with the best possible treatment, skin care advice and follow-up care • Understand challenges of palliative and supportive care in NMSC patients • Have a general understanding of principles in geriatric oncology and integrate geriatric oncology assessment into clinical practice involving NMSC patients • Summarise the latest technical

BACKGROUND Recently there has been an alarming increase in skin cancer incidence worldwide,

92

SCHOOL